Martin Söderberg

648 total citations
18 papers, 419 citations indexed

About

Martin Söderberg is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Martin Söderberg has authored 18 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Martin Söderberg's work include Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers) and Breast Cancer Treatment Studies (5 papers). Martin Söderberg is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers) and Breast Cancer Treatment Studies (5 papers). Martin Söderberg collaborates with scholars based in Sweden, Finland and Norway. Martin Söderberg's co-authors include Kenneth Villman, A. Thörne, Peter Wersäll, Mats Remberger, Jonas Mattsson, Mehmet Uzunel, Olle Ringdén, Juha Martola, Pavel Pisa and Annika Wernerson and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Martin Söderberg

18 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Söderberg Sweden 11 282 109 105 95 66 18 419
H Dazzi Switzerland 10 166 0.6× 192 1.8× 32 0.3× 77 0.8× 53 0.8× 18 427
Meghan Campo United States 7 272 1.0× 235 2.2× 50 0.5× 149 1.6× 59 0.9× 9 489
R Ueda Japan 9 103 0.4× 118 1.1× 54 0.5× 47 0.5× 107 1.6× 23 380
S. Giralt United States 5 218 0.8× 50 0.5× 93 0.9× 325 3.4× 57 0.9× 18 486
Donald Woytowitz United States 11 477 1.7× 397 3.6× 64 0.6× 90 0.9× 172 2.6× 19 731
Boyd Mudenda United States 10 270 1.0× 86 0.8× 53 0.5× 21 0.2× 98 1.5× 20 435
Giovenzio Genestreti Italy 13 261 0.9× 246 2.3× 53 0.5× 90 0.9× 196 3.0× 35 533
Karl Verpoort Germany 7 222 0.8× 53 0.5× 98 0.9× 28 0.3× 64 1.0× 10 370
Louis A. VanderMolen United States 12 220 0.8× 45 0.4× 24 0.2× 49 0.5× 56 0.8× 23 382
Kazuhiko Natori Japan 6 88 0.3× 70 0.6× 49 0.5× 70 0.7× 15 0.2× 14 263

Countries citing papers authored by Martin Söderberg

Since Specialization
Citations

This map shows the geographic impact of Martin Söderberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Söderberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Söderberg more than expected).

Fields of papers citing papers by Martin Söderberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Söderberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Söderberg. The network helps show where Martin Söderberg may publish in the future.

Co-authorship network of co-authors of Martin Söderberg

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Söderberg. A scholar is included among the top collaborators of Martin Söderberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Söderberg. Martin Söderberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Emilsson, Louise, et al.. (2018). High experienced continuity in breast cancer care is associated with high health related quality of life. BMC Health Services Research. 18(1). 127–127. 19 indexed citations
2.
Söderberg, Martin, et al.. (2018). Sociodemographic Characteristics and Health Profile of the Elderly Seeking Health Care in Kampala, Uganda. Current Gerontology and Geriatrics Research. 2018. 1–9. 10 indexed citations
3.
4.
Kimbung, Siker, Ida Johansson, Anna Danielsson, et al.. (2015). Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis–Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer. Clinical Cancer Research. 22(1). 146–157. 36 indexed citations
5.
Suzuki, Takayuki, Lennart Blomqvist, Thomas Hatschek, et al.. (2013). Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy. Medical Oncology. 30(1). 415–415. 6 indexed citations
6.
Bjöhle, Judith, Jenny Bergqvist, J. Simon Gronowitz, et al.. (2013). Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial. Breast Cancer Research and Treatment. 139(3). 751–758. 28 indexed citations
7.
Hatschek, Thomas, Lena Carlsson, Zakaria Einbeigi, et al.. (2011). Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial. Breast Cancer Research and Treatment. 131(3). 939–947. 23 indexed citations
8.
9.
Hatschek, Thomas, Zakaria Einbeigi, Thomas Walz, et al.. (2010). 468 Individually dose-adjusted treatment with epirubicin and paclitaxel with or without capecitabine as 1st line treatment in metastatic breast cancer. A randomized multicenter trial. European Journal of Cancer Supplements. 8(3). 195–196. 1 indexed citations
10.
Villman, Kenneth, Johanna Sjöström, Reino Heikkilä, et al.. (2006). TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer. Acta Oncologica. 45(5). 590–596. 43 indexed citations
11.
Pérez-Manga, G., Manuel Constenla, A. Ruíz, et al.. (2004). Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer. British Journal of Cancer. 90(9). 1740–1746. 42 indexed citations
12.
Hentschke, P, Lisbeth Barkholt, Mehmet Uzunel, et al.. (2003). Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. Bone Marrow Transplantation. 31(4). 253–261. 120 indexed citations
13.
Andersson, J., Barbro Linderholm, Birgitta Lindh, et al.. (2002). A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden. Acta Oncologica. 41(3). 276–281. 11 indexed citations
14.
Ljungman, Per, Bo Björkstrand, Tommy� Fornander, et al.. (1998). High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer. Bone Marrow Transplantation. 22(5). 445–448. 9 indexed citations
15.
Sæter, Gunnar, Thor Alvegård, Odd R. Monge, et al.. (1997). Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian sarcoma group phase II study. European Journal of Cancer. 33(10). 1551–1558. 32 indexed citations
16.
Gjedde, Susanne B., Henning T. Mouridsen, Niels Viggo Jensen, et al.. (1993). Phase I study of tauromustine administered in a weekly schedule. European Journal of Cancer. 29(13). 1901–1902. 2 indexed citations
17.
Hrafnkelsson, Jón, Kristofer F. Nilsson, & Martin Söderberg. (1987). Tolerance of Radiotherapy Combined with Adjuvant Chemotherapy in Breast Cancer. Acta Oncologica. 26(4). 269–272. 12 indexed citations
18.
Håkansson, Leif, et al.. (1984). Tumour regression after extracorporeal affinity chromatography of blood plasma across agarose beads containing staphylococcal protein A. European Journal of Cancer and Clinical Oncology. 20(11). 1377–1388. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Dazzi Breakdown of academic impact, for papers by Meghan Campo Breakdown of academic impact, for papers by R Ueda Breakdown of academic impact, for papers by S. Giralt Breakdown of academic impact, for papers by Donald Woytowitz Breakdown of academic impact, for papers by Boyd Mudenda Breakdown of academic impact, for papers by Giovenzio Genestreti Breakdown of academic impact, for papers by Karl Verpoort Breakdown of academic impact, for papers by Louis A. VanderMolen Breakdown of academic impact, for papers by Kazuhiko Natori
Rankless by CCL
2026